# TRAGACANTH

URL: https://app.greenveil.ai/ingredients/ingredient_dtxsid_dtxsid2021369
Categories: beauty, cleaning, food, pharma
Functions: Adhesion/cohesion promoter, Binder, Deodorizer, Emulsifier, Film former, Flavouring and nutrient, Foamant, Fragrance, Processing aids not otherwise specified, Stabilizing agent, Thickening agent, Viscosity modifier
Identifier: DTXSID2021369

> TRAGACANTH is used as adhesion/cohesion promoter / binder. EPA CPDat observed this chemical in 19 composition records across product categories including Food and drug, Personal care. Assessed from 18 sources.

## Safety assessment

- Chemical concern: not yet assessed
- Rationale: EPA CPDat observed this chemical in 19 composition records across product categories including Food and drug, Personal care.

## Regulatory status

- US: commercial use observed — EPA CPDat observed this chemical in 19 composition records across product categories including Food and drug, Personal care. EPA CPDat classifies this chemical for functional uses including Film former, Deodorizer, Viscosity modifier.
- US: inactive ingredient database — Route: BUCCAL; Dosage form: TABLET; Potency: 5 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Potency: 60 mg/1ml
- US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 130 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION, EXTENDED RELEASE; Maximum daily exposure: 70 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 12 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, COATED; Potency: 7.5 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Potency: NA
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Potency: 7 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: WAFER; Potency: 32 mg
- US: inactive ingredient database — Route: SUBLINGUAL; Dosage form: TABLET; Potency: 5 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: JELLY; Potency: NA
- US: marketed drug occurrence — FDA NDC lists this ingredient in 2 active drug products and 2 total products.
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as concept.
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as structurallydiverse.

_Assessed by Greenveil._